ScreenerHero

ORX Orexo AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · orexo.com
13.40SEK0.00%Mkt Cap: 45.02M $P/E: —

Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products in…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap45.02M USD
Enterprise Value19.48M USD
Revenue (TTM)1.59M USD
Gross Profit1.10M USD
Net Income (TTM)61.15M USD
Revenue/Share0.48 SEK
Last Price13.40 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees61
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.13
PEG13.07
EV/EBITDA-0.64
EV/Revenue12.27
P/S28.36
P/B1.73
EPS (TTM)-10.14
EPS (Forward)-4.28
52W Range
12.204% of range43.40
52W High43.40 SEK
52W Low12.20 SEK
Profitability
Gross Margin44.23%
Oper. Margin-2945.71%
EBITDA Margin0.00%
Profit Margin2458.85%
ROE130.31%
ROA49.07%
Growth
Revenue Growth-27.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.69M USD
CapEx (TTM)—
FCF Margin-366.42%
FCF Yield-12.92%
Net Debt-25.54M USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity1.00
Current Ratio1.65
Quick Ratio1.59
Book Value/Sh7.72 SEK
Cash/Share7.88 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)26.50 SEK
Upside (mean)+97.8%
Target Range26.50 SEK – 26.50 SEK
# Analysts2
Ownership
Shares Out.35.13M
Float22.55M
Insiders10.13%
Institutions48.16%
Technical
SMA 5014.05 (-4.7%)
SMA 20021.38 (-37.3%)
Beta0.85
S&P 52W Chg14.58%
Avg Vol (30d)41.44K
Avg Vol (10d)33.81K
Technical Indicators
RSI (14)46.1
MACD-0.3083
MACD Signal-0.4915
MACD Hist.+0.1832
BB Upper14.26 SEK
BB Middle13.21 SEK
BB Lower12.16 SEK
BB Width15.86%
ATR (14)0.8126 SEK
Vol Ratio (20d)0.38x